BidaskClub upgraded shares of Bruker (NASDAQ:BRKR) from a hold rating to a buy rating in a research report sent to investors on Wednesday.
Other research analysts also recently issued reports about the company. UBS Group assumed coverage on Bruker in a research note on Tuesday, October 9th. They issued a sell rating and a $30.00 price target for the company. They noted that the move was a valuation call. ValuEngine downgraded Bruker from a hold rating to a sell rating in a research note on Wednesday, July 11th. Morgan Stanley raised their price target on Bruker from $29.00 to $31.00 and gave the company an equal weight rating in a research note on Friday, August 3rd. Finally, Zacks Investment Research downgraded Bruker from a hold rating to a sell rating in a research note on Tuesday, July 24th. Three analysts have rated the stock with a sell rating, four have issued a hold rating and three have issued a buy rating to the company’s stock. The stock has an average rating of Hold and an average target price of $34.63.
Bruker stock traded down $1.07 during midday trading on Wednesday, reaching $33.83. The stock had a trading volume of 736,982 shares, compared to its average volume of 718,089. Bruker has a 1-year low of $28.13 and a 1-year high of $36.53. The firm has a market cap of $5.40 billion, a PE ratio of 27.96, a P/E/G ratio of 2.11 and a beta of 1.34. The company has a debt-to-equity ratio of 0.26, a quick ratio of 1.27 and a current ratio of 2.22.
Hedge funds have recently bought and sold shares of the business. SG Americas Securities LLC bought a new position in shares of Bruker during the 2nd quarter worth approximately $101,000. Sun Life Financial INC bought a new position in shares of Bruker during the 2nd quarter worth approximately $163,000. Crossmark Global Holdings Inc. bought a new position in shares of Bruker during the 3rd quarter worth approximately $205,000. Private Advisor Group LLC bought a new position in shares of Bruker during the 3rd quarter worth approximately $210,000. Finally, First Hawaiian Bank bought a new position in shares of Bruker during the 3rd quarter worth approximately $248,000. Hedge funds and other institutional investors own 64.86% of the company’s stock.
Bruker Company Profile
Bruker Corporation manufactures and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates in two segments, Bruker Scientific Instruments, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry systems; infrared spectroscopy and radiological/nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection in emergency response, homeland security, and defense applications; and research, analytical, and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies.
Featured Article: Why investors pay attention to retained earnings
Receive News & Ratings for Bruker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker and related companies with MarketBeat.com's FREE daily email newsletter.